Analysis of Headache Chronification With Imaging, Deep Phenotyping, &

Status Recruiting

Clinical Trial Summary

Study is aimed at determining why some patients with episodic headache proceed to chronic daily or near daily headaches. The Investigators seek to discover differences in brain anatomy and function, composition of cerebrospinal fluid, blood products, genetics, and patient phenotypes that might help explain this process.

Clinical Trial Description

The purpose of our study is to better understand disease processes and risk factors involved in onset of chronic daily headaches/Chronic Migraines. Further, The Investigators hopes to learn more about the etiology and disease mechanisms to optimize treatment strategies and determine prophylactic measures. Participation in this research study, will include online questionnaires, a blood sample, a lumbar puncture, and a magnetic resonance imaging (MRI) scan without contrast to measure brain activity. Participant may select to participate in a magnetic resonance imaging (MRI) scan and/ or lumbar puncture. participating in atleast 3 procedures is required (blood draw, online questionnaires , MRI and/or Spinal Tap. The study recruits participants with headache ( any type of headaches), and patients with no headaches ( or less than 2/year). Participants do not need to have a specified headache type. All participants are asked to complete an on-line survey to characterize a number of phenotypic features felt to be relevant by the Investigators. Three independent study groups (imaging, proteomics/genetics, and phenotyping) analyze data independently and stratify the data. Then, by group analysis, correlation among the different modalities is sought to identify features that distinguish common elements that might help elucidate features that could predict which patients with episodic headache are likely to progress to chronic, and which patients without headache might be at greater risk to develop new daily persistent headache. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03231241
Study type	Observational
Source	Stanford University
Contact	Bharati Sanjanwala, M.Sc.
Phone	650-721-2830
Email	bharatis@stanford.edu
Status	Recruiting
Phase
Start date	December 12, 2014
Completion date	September 1, 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05720819` - Biofeedback-VR for Treatment of Chronic Migraine	N/A
Not yet recruiting	`NCT06428838` - Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context	Phase 3
Recruiting	`NCT05517200` - Pilot Study for a Machine Learning Test for Migraine
Recruiting	`NCT05891808` - miR-155 Expression in Episodic and Chronic Migraine
Completed	`NCT02514148` - Biobehavioral Physical Therapy Strategies Based on Therapeutic Exercise Applied to Chronic Migraine Patients	N/A
Enrolling by invitation	`NCT02291380` - A Study to Evaluate Botulinum Toxin Type A for Injection（HengLi®）for Prophylactic Treatment of Chronic Migraine	Phase 3
Completed	`NCT02122237` - Cathodal tDCS in Chronic Migraine: Neurophysiological Study and Pilot Therapeutic Trial	Phase 3
Withdrawn	`NCT02122744` - RCT Versus Placebo of rTMSQP Over Visual Cortex for the Prevention of Chronic Migraine	N/A
Recruiting	`NCT02202486` - Investigation of the Blood-brain and Blood-dura Barrier Durin Migraine Attacks Using MRI	N/A
Completed	`NCT01709708` - Use of the Tx360 Nasal Applicator in the Treatment of Chronic Migraine	Phase 4
Completed	`NCT01741246` - Neuroimaging Studies of Chronic Primary Headaches Using Positron Emission Tomography and Magnetic Resonance Imaging	N/A
Completed	`NCT01090050` - Treximet in the Treatment of Chronic Migraine	Phase 4
Recruiting	`NCT03507400` - Introvision for Migraine and Headaches	N/A
Completed	`NCT04161807` - Efficacy and Safety of Nerivio™ for Acute Treatment of Migraine in People With Chronic Migraine	N/A
Completed	`NCT03175263` - OnabotulinumtoxinA Injections in Chronic Migraine, Targeted to Sites of Pericranial Myofascial Pain	N/A
Withdrawn	`NCT04353505` - Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache	Phase 1
Completed	`NCT01667250` - Non-Invasive Neurostimulation for the Prevention of Chronic Migraine	N/A
Completed	`NCT01700387` - A Study to Evaluate the Tolerability of Botox and Topiramate or Botox and Placebo and Effect on Cognitive Efficiency	Phase 4
Not yet recruiting	`NCT01135784` - Study of MIGRA-ZEN RELIEF PLUS In the Treatment of Chronic Migraine Headache	Phase 2
Completed	`NCT00772031` - NINDS CRC Chronic Migraine Treatment Trial	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms